These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24407031)

  • 1. AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses.
    Zhou HJ; Chen X; Huang Q; Liu R; Zhang H; Wang Y; Jin Y; Liang X; Lu L; Xu Z; Min W
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):603-15. PubMed ID: 24407031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.
    Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice.
    Zhang H; He Y; Dai S; Xu Z; Luo Y; Wan T; Luo D; Jones D; Tang S; Chen H; Sessa WC; Min W
    J Clin Invest; 2008 Dec; 118(12):3904-16. PubMed ID: 19033661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM; Tsai CH; Hung WC
    Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
    Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
    Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.
    Matsumoto M; Roufail S; Inder R; Caesar C; Karnezis T; Shayan R; Farnsworth RH; Sato T; Achen MG; Mann GB; Stacker SA
    Clin Exp Metastasis; 2013 Aug; 30(6):819-32. PubMed ID: 23591595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.
    Nakao S; Zandi S; Hata Y; Kawahara S; Arita R; Schering A; Sun D; Melhorn MI; Ito Y; Lara-Castillo N; Ishibashi T; Hafezi-Moghadam A
    Blood; 2011 Jan; 117(3):1081-90. PubMed ID: 20705758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.
    Tammela T; Zarkada G; Nurmi H; Jakobsson L; Heinolainen K; Tvorogov D; Zheng W; Franco CA; Murtomäki A; Aranda E; Miura N; Ylä-Herttuala S; Fruttiger M; Mäkinen T; Eichmann A; Pollard JW; Gerhardt H; Alitalo K
    Nat Cell Biol; 2011 Sep; 13(10):1202-13. PubMed ID: 21909098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis.
    Jones D; Li Y; He Y; Xu Z; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):633-42. PubMed ID: 22223733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.
    Cao R; Ji H; Feng N; Zhang Y; Yang X; Andersson P; Sun Y; Tritsaris K; Hansen AJ; Dissing S; Cao Y
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15894-9. PubMed ID: 22967508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.
    Lee S; Rho SS; Park H; Park JA; Kim J; Lee IK; Koh GY; Mochizuki N; Kim YM; Kwon YG
    J Clin Invest; 2017 Feb; 127(2):457-471. PubMed ID: 27991863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3.
    Matsumura K; Hirashima M; Ogawa M; Kubo H; Hisatsune H; Kondo N; Nishikawa S; Chiba T; Nishikawa S
    Blood; 2003 Feb; 101(4):1367-74. PubMed ID: 12393458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.
    Chung ES; Chauhan SK; Jin Y; Nakao S; Hafezi-Moghadam A; van Rooijen N; Zhang Q; Chen L; Dana R
    Am J Pathol; 2009 Nov; 175(5):1984-92. PubMed ID: 19808642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.
    Zhang H; Zhang R; Luo Y; D'Alessio A; Pober JS; Min W
    J Biol Chem; 2004 Oct; 279(43):44955-65. PubMed ID: 15310755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.
    Zhang H; Zhang H; Lin Y; Li J; Pober JS; Min W
    J Biol Chem; 2007 May; 282(20):14788-96. PubMed ID: 17389591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.